Literature DB >> 21123980

Efficacy of revascularization surgery for moyamoya syndrome associated with Graves' disease.

Hidenori Endo1, Miki Fujimura, Kuniyasu Niizuma, Hiroaki Shimizu, Teiji Tominaga.   

Abstract

Appropriate management of moyamoya syndrome associated with Graves' disease is undetermined because of the rarity of this combination. Patients tend to present with cerebrovascular events such as transient ischemic attack (TIA) in a thyrotoxic state, which is relieved by proper antithyroid therapy. Four patients with moyamoya syndrome associated with Graves' disease were successfully treated with revascularization surgery on 5 hemispheres among 58 consecutive patients (2-62 years old, mean 34.4 years) with moyamoya disease in 80 hemispheres treated from March 2004 to May 2007. Three patients presented with TIA, and one patient presented with intracerebral hemorrhage. Three patients were thyrotoxic at the onset of the cerebrovascular events. All patients underwent revascularization surgery after normalization of thyroid function. Euthyroid state was strictly maintained perioperatively. One patient developed symptomatic cerebral hyperperfusion, which was resolved by blood pressure control. Postoperative courses of the other patients were uneventful, and all 4 patients have remained neurologically stable after discharge. Cerebrovascular reconstruction surgery is a successful treatment option for moyamoya syndrome associated with Graves' disease. Timing of surgery during the euthyroid state and perioperative management considering the thyroid function and the cerebral hemodynamic change are the keys to successful surgical treatment.

Entities:  

Mesh:

Year:  2010        PMID: 21123980     DOI: 10.2176/nmc.50.977

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  4 in total

1.  Champagne bottle neck sign in a patient with Moyamoya syndrome.

Authors:  Takafumi Shimogawa; Takato Morioka; Tetsuro Sayama; Takeshi Hamamura; Chiharu Yasuda; Shuji Arakawa
Journal:  World J Clin Cases       Date:  2014-09-16       Impact factor: 1.337

2.  Fatal outcome in a Hispanic woman with moyamoya syndrome and Graves' disease.

Authors:  Julian Choi; Perin Suthakar; Farbod Farmand
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2016-11-04

3.  Identification of HLA-DRB1*04:10 allele as risk allele for Japanese moyamoya disease and its association with autoimmune thyroid disease: A case-control study.

Authors:  Ryosuke Tashiro; Kuniyasu Niizuma; Seik-Soon Khor; Katsushi Tokunaga; Miki Fujimura; Hiroyuki Sakata; Hidenori Endo; Hidetoshi Inoko; Koetsu Ogasawara; Teiji Tominaga
Journal:  PLoS One       Date:  2019-08-14       Impact factor: 3.240

4.  Acute Thrombectomy for Contralateral Internal Carotid Artery Occlusion after Revascularization Surgery for Quasi-moyamoya Disease: A Case Report.

Authors:  Shotaro Ogawa; Daisuke Sato; Seiei Torazawa; Takahiro Ota
Journal:  NMC Case Rep J       Date:  2021-10-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.